Abstract
The pediatric lupus patients are required to meet the American College of Rheumatology (ACR) minimum criteria to be included in the research cohort and considered for aggressive therapy. This approach may delay early aggressive therapy.
Highlights
The pediatric lupus patients are required to meet the American College of Rheumatology (ACR) minimum criteria to be included in the research cohort and considered for aggressive therapy
Out of 98 pediatric systemic lupus erythematosus (pSLE) patients 71% were included in definitive pSLE (D pSLE) group while 28.57% were included in
PpSLE were more likely to have higher male: female ratio (p = 0.032), and were older at presentation that D pSLE (p = 0.045).PpSLE patients were less likely to have internal organ involvement (7.1% Vs 25.7%), were less likely to be hospitalized and receive pulse steroids (p = 0.0142) or oral steroids (0.0172) at presentation
Summary
PReS-FINAL-2351: Children with probable SLE by ACR criteria may need more aggressive lupus treatment early in the disease course Introduction The pediatric lupus patients are required to meet the American College of Rheumatology (ACR) minimum criteria to be included in the research cohort and considered for aggressive therapy.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
